Important note: Information in this article was accurate in November 2009. The state of the art may have changed since the publication date.
Introduction
HIV Treat Bull - 2009 Nov/Dec;10(11/12): 15
The following short reports are summaries from some of the interesting studies presented at ICAAC this year. As were not able to cover this meeting in person, all information is dependent on the online posters.
Reports in this issue of HTB include:
Recent ARVs and the blood/brain barrier: CSF drug concentrations of darunavir/r and raltegravir
Alcohol and marijuana may reduce drug levels of atazanavir and efavirenz
Raltegravir body composition study: 48-week DEXA results ICAAC unfortunately routinely removes online access shortly after the meeting and is one of the few medical meetings covering HIV care that does not support continued open access to this resource.
As we went to press these were still available online:
http://www.posters2view.com/icaac
[Username: ICAAC; Password: SanFran]
2009-11-10
IB2009-11-15
©2009. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in November 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.